Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Descrição
Transcriptional addiction in mixed lineage leukemia: new avenues for target therapies
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International
Covalent and noncovalent constraints yield a figure eight-like conformation of a peptide inhibiting the menin-MLL interaction - ScienceDirect
PDF) Menin–MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers
Biomedicines, Free Full-Text
IJMS, Free Full-Text
Cancers, Free Full-Text
Challenges and opportunities in targeting the menin-MLL interaction. - Abstract - Europe PMC
Molecules, Free Full-Text
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Structure and in vitro activity of menin-MLL1 inhibitor MI-3454. (A)
Challenges and opportunities in targeting the menin-MLL interaction.
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Current status and future perspectives in targeted therapy of NPM1-mutated AML
de
por adulto (o preço varia de acordo com o tamanho do grupo)
